Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

7,313 total articles

Royal Caribbean International CEO Disposes $26.1M in Shares as Company Posts In-Line Q4 Results and Receives Rating Upgrade

Royal Caribbean International CEO Disposes $26.1M in Shares as Company Posts In-Line Q4 Results and Receives Rating Upgrade

Michael W. Bayley, President and CEO of Royal Caribbean International, sold 79,894 shares of Royal Caribbean Cruises Ltd. common stock in a set of transactions on February 13, 2026, at prices between $322.66 and $332.19 for a total of $26,145,463. After the disposals, Bayley retains direct ownership of 58,108 shares. Separately, Royal Caribbean rep…

Ionis Research EVP Sells $1.27M in Stock as Company Posts Multiple Clinical and Regulatory Milestones

Ionis Research EVP Sells $1.27M in Stock as Company Posts Multiple Clinical and Regulatory Milestones

Eric Swayze, Executive Vice President of Research at Ionis Pharmaceuticals (IONS), sold 15,642 shares on February 13, 2026, in two transactions totaling roughly $1.27 million under a Rule 10b5-1 plan. The stock has risen sharply over the past year and is trading near its 52-week high as the company reports several clinical and regulatory achievemen…

Mineralys CMO Sells $569,809 in Stock While Exercising Options; Company Advances Lorundrostat Program

Mineralys CMO Sells $569,809 in Stock While Exercising Options; Company Advances Lorundrostat Program

Mineralys Therapeutics Chief Medical Officer David Malcom Rodman sold 14,676 shares of the companys common stock for roughly $569,809 across February 12 and 13, 2026, while exercising options to acquire 14,056 shares valued at $102,340. The trades were executed under a Rule 10b5-1 plan adopted October 6, 2025. Separately, the companys lead candidat…

BlackRock Senior Managing Director Disposes of $2.34M in Stock; Firm Sees Positive Analyst Response to Q4

BlackRock Senior Managing Director Disposes of $2.34M in Stock; Firm Sees Positive Analyst Response to Q4

Stephen Cohen, a senior managing director at BlackRock, sold 2,179 shares of the company's common stock on February 11, 2026, at $1,073.87 per share, yielding $2.34 million. The firm’s strong fourth-quarter results prompted upward price-target revisions from UBS and Keefe, Bruyette & Woods, while governance and leadership movements - including a ne…

McKesson Executive Sells 303 Shares as Company Posts Q3 Beat

McKesson Executive Sells 303 Shares as Company Posts Q3 Beat

Michele Lau, McKesson's Executive Vice President and Chief Legal Officer, sold 303 shares on February 11, 2026 under a previously adopted 10b5-1 plan. The transaction reduced her direct stake to 5,972 shares; she also holds an indirect interest through the company's 401(k) plan. The sale coincides with McKesson's fiscal third-quarter 2026 results, …

Caterpillar Group President Disposes of $9.59M in Shares; Exercises Options Amid Strong Q4 Results

Caterpillar Group President Disposes of $9.59M in Shares; Exercises Options Amid Strong Q4 Results

Group President Bob De Lange sold 12,507 shares of Caterpillar common stock on February 11, 2026, realizing roughly $9.59 million through multiple trades. The Form 4 filing also records option exercises and an additional disposition, and shows De Lange’s post-transaction direct ownership at 84,997 shares. Separately, Caterpillar reported fourth-qua…